These devices are used to simultaneously detect and identify a panel of mutations and variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene in human blood specimens. Both panels include 23 mutations and 4 variants currently recommended by the American College of Medical Genetics and American College of Obstetricians and Gynecologists (ACMG/ACOG), plus some of the worlds most common and North American-prevalent mutations.  These assays are qualitative genotyping tests which provides information intended to be used for carrier testing in adults of reproductive age, as an aid in newborn screening, and in confirmatory diagnostic testing in newborns and children.

Benefits:

• Confidence:   
  Second generation of IVD assay 
  >99.9% Precision and Reproducibility
  

• Comprehensive:   
  Most comprehensive mutation coverage, including ACMG/ACOG recommended panel
  

• Flexibility:    
  Mutation panel selection through the software
  

• Ease of Use:    
  Streamlined protocol with minimal hands-on time
  

• Cost-Effective Multiplex Genotyping:  
  Reduced repeat rate 
  No reflex testing is necessary

*Product not available in Canada.
** Product not available in the USA and Canada.

Products listed are region specific and intended for residents of a particular country/region; this site contains information on devices that may not be approved in some countries/regions, therefore please contact Luminex to obtain the appropriate product info for your country of residence.